tiprankstipranks
Trending News
More News >
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market
Advertisement

Monte Rosa Therapeutics (GLUE) Similar Stocks

Compare
342 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Monte Rosa Therapeutics
$16.86
$1.00B
55.21
70.99%
4 Buy
0 Hold
0 Sell
Strong Buy
CytomX Therapeutics
$4.00
$645.55M
9.11
210.08%
6 Buy
1 Hold
0 Sell
Strong Buy
Fulcrum Therapeutics
$9.06
$635.35M
140.32%
7 Buy
1 Hold
1 Sell
Moderate Buy
Monopar Therapeutics Inc
$77.18
$507.48M
213.00%
12 Buy
0 Hold
0 Sell
Strong Buy
Opthea Limited Sponsored ADR
$0.20
$477.76M
-3.01
-94.49%
0 Buy
0 Hold
0 Sell
Hold
Inhibrx Biosciences Inc
$82.96
$1.22B
453.07%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GLUE
Monte Rosa Therapeutics
16.86
7.62
82.47%
CTMX
CytomX Therapeutics
4.00
2.71
210.08%
FULC
Fulcrum Therapeutics
9.06
5.55
158.12%
MNPR
Monopar Therapeutics Inc
77.18
52.52
212.98%
OPT
Opthea Limited Sponsored ADR
0.20
-3.41
-94.46%
INBX
Inhibrx Biosciences Inc
82.96
67.86
449.40%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis